Nevertheless, the anti-microglial anti-inflammatory antibiotic, minocycline showed evidence of efficacy in depression in two clinical trials (see [28]), suggesting the raised PET TSPO binding could reflect a causal inflammatory process and possibly microgliosis. Here, TSPO is linked to depressive symptom measurement.